Switch from Atripla to Stribild for sleep and cognition in HIV

Phase 4, randomised, open-label trial of emtricitabine + elvitegravir + cobicistat + tenofovir disoproxil in human immunodeficiency virus infection (HIV) (2 arms), sponsored by University of Hawaiʻi. Primary endpoints: Change in sleep architecture assessed by formal sleep study at 12 weeks and Change in neuropsychological performance global and subdomain neuropsychological test scores at 12 weeks. Status: unknown.